Straight answers
Everything owners ask us, answered in one place.
Published so you don't have to call to learn any of it. Anything missing — the email in the footer reaches a human.
Understanding it
Is unknown-origin revenue actually a problem? The money still arrives.
It arrives — we say so plainly, and our estimate is labeled a FLOW, not a loss. The problem is steering: every renewal, cut, and new-spend decision touching that flow is made blind. The channel quietly carrying you gets no protection; the loud one producing nothing gets renewed. The free score sizes your blind share in three minutes.
Isn't perfect attribution impossible for a local business?
Yes — and we say that on the fix page. Word of mouth, the sign, the drive-past: some origin stays soft forever. The goal isn't 100%; it's shrinking a 60% unknown to a 20% one, so most of the money answers to evidence. Vendors promising total attribution are selling weather control.
My ad platform already shows me conversions.
It shows you ITS conversions, defined by its own rules, counted by its own tools — homework it graded itself. Real attribution lives where the money lands: your bookings, your records, your deposits. The trace runs there, which is why its numbers frequently disagree with the platform's.
How is this different from the paid-leads door in your network?
Sister doors: Half Never Got Called audits whether purchased leads got worked. This door asks the question that comes BEFORE the buying: which channels deserve your money at all. Blind practices tend to buy more leads; traced ones buy better.
Is my business a fit?
Who is this for?
Local businesses spending real money on marketing without evidence about what it produces: dental and medical practices, home services and trades, legal and professional services, and anyone whose renewal decisions currently run on gut feel.
We barely spend on marketing — mostly word of mouth. Relevant?
Differently relevant: your unknown share is probably huge and your risk is misdiagnosis — believing it's all word of mouth while the Google profile quietly does half the work (or vice versa). Owners who "don't market" still make cut-or-invest decisions; they just make them about their time instead of ad budgets.
We're part of a franchise / the marketing is corporate. Useful?
The trace works at whatever level you control: local spend, local Google profile, local capture at YOUR desk. Knowing your location's real origins is also the strongest card you can hold in any conversation with corporate about co-op dollars.
Does the trace involve patient data or PHI?
We work IN your records with your written permission and take nothing identifying out — findings aggregate by channel, never by person. For healthcare practices, the deliverable contains no patient identifiers, and we'll sign what your compliance posture requires before touching anything.
How it works
What's in the free assessment?
Ten questions: business type, arrival volume, which paths are tracked, your honest attributed share, capture habit, spend-feedback speed, where answers go, ownership, relationship value. You get a 0–100 score, four axis scores worst-first, and a written report with a monthly unknown-origin estimate.
Who writes the report?
The written analysis is produced by Claude, an AI model, from your answers and computed scores only — every claim traces to something you said. The scoring is published, deterministic math. We name the AI because it's true.
What does the $500 discovery actually involve?
One recent month of new arrivals, followed through the records you already have — booking entries, call logs, form timestamps, intake answers — matched to origins where the evidence supports it, every match and dead end timestamped. Nothing installed, no vendor consulted. You get revenue-by-origin where knowable, the measured unknown share, and the drop-point map.
How much of my staff's time does it take?
Access plus about an hour of questions across the five days — the work is archival, and we do it. The deliverable session takes one more hour, with the drop-point map on the table.
Money, after, and objections
Why pay $500 to learn where my patients come from?
Because the free alternatives are the reasons you're blind: self-graded vendor reports, a web-only analytics view, and sometimes-asked questions. The $500 buys the version none of them can produce — origins matched to YOUR revenue in YOUR records, timestamped. It's also priced so "your attribution is fine" is an affordable answer.
What do fixes cost?
Builds start at $2,500, quoted in writing after the discovery, scoped to your actual drop-point map — capture workflow, tracked paths, the monthly source page. The floor is published because hidden prices waste everyone's time.
What happens after I get my score?
You have the report and the estimate. Small unknown share — keep doing what you're doing, you're done. Large one — the report's next step is the discovery, booked and prepaid online in one step. No sales sequence beyond three emails that end on schedule.
How do I know you won't inflate the unknown share to sell a build?
Three structural answers: the discovery is priced to stand alone, so "you're fine" is a deliverable we can afford; every trace finding carries timestamps you can check in your own records; and our estimate math is published on the cost page with its assumptions, including the fact that it's a flow, not a loss. Understating is our tell.
Never heard of you. Why trust you?
Don't — verify. The score is free and shows its work. The trace is $500 against your own records, where you can check every claim. Who we are: about page.
Three minutes answers most of this for your business specifically
Your channels, your blind share, your numbers.
Score your attribution blindness